Informing Canada’s cancer drug funding decisions with scientific evidence and patient perspectives: the pan-Canadian Oncology Drug Review

J.S. Hoch, M. Sabharwal

Abstract


-

Full Text:

PDF HTML


DOI: http://dx.doi.org/10.3747/co.20.1315






Copyright © 2019 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)